Perioperative Systemic Therapy and Surgery Versus Surgery Alone for Resectable Colorectal Peritoneal Metastases: the Multicentre, Phase II-III, Randomised CAIRO6 Study.
Phase of Trial: Phase II/III
Latest Information Update: 05 Jun 2017
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer; Peritoneal cancer
- Focus Therapeutic Use
- Acronyms CAIRO-6
- 05 May 2017 Planned primary completion date changed from 1 Jan 2024 to 1 Aug 2024.
- 05 May 2017 Status changed from not yet recruiting to recruiting.
- 04 May 2017 Planned number of patients changed from 340 to 358.